P/E Ratio
Updated 9h ago
Sector Performance
8th percentileCINF
10.2x
Sector Median
24.7x
Sector Avg
36.0x
Deep Analysis
The current price-to-earnings (P/E) ratio of 10.2x means investors are paying $10.20 for every $1 of the company’s annual earnings — a relatively low valuation.
Among sector peers, the median P/E is 24.7x, placing this stock at the 8th percentile, meaning it is cheaper than 92% of comparable companies. The year-over-year change is not available, but compared to the prior quarter the ratio increased by 6.2% from 9.6x to 10.2x. A low P/E often signals a potential value opportunity, but the recent upward trend suggests earnings may be declining or the stock price is rising faster than earnings, introducing uncertainty about whether the discount will persist. This combination of a low level with a rising trend supports a cautious view: the cheap valuation offers a margin of safety, but the increase could indicate underlying earnings weakness. Therefore, this metric aligns with the overall NEUTRAL verdict — the low P/E is appealing, yet the recent rise and lack of long-term trend data prevent a more decisive bullish or bearish stance.
Frequently Asked Questions
What does the P/E Ratio tell investors about CINF?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are CINF's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master CINF's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CINF research report →CINF
10.2x
Sector Median
24.7x
Sector Avg
36.0x
How CINF's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.